CAPhO Oncology Fundamentals Day 2024: 2nd November 2024

CAPhO Oncology Fundamentals Day 2024: Saturday, November 2, 2024, 10:00 – 18:30 EDT

 

Are you a pharmacist or technician NEW TO ONCOLOGY PRACTICE? Are you a pharmacy STUDENT or RESIDENT with an interest in oncology? Are you interested in FOUNDATIONAL oncology education? 

 

If you answered YES to any of these questions…

 

Plan to attend the CAPhO Oncology Fundamentals Day, taking place on Saturday, November 2, 2024 from 10:00 – 18:30 EDT as a one day ONLINE learning event. Register by Wednesday, October 2, 2024 to save!

 

The Oncology Fundamentals Day will feature CCCEP accredited sessions, streamed online so you can attend the event live from wherever you are. The program features the following topics:

  • Navigating Difficult Conversations with Patients
  • BPMH in Ambulatory Oncology Pharmacy Practice
  • Overview of Breast Cancer
  • Drug Interactions with Immunotherapy
  • Diagnostic Tests in the Management of Cancer
  • Overview of CML (Chronic Myeloid Leukemia)
  • Overview of Managing Sexual Health in Cancer

Not a member of CAPhO? You are welcome to attend this professional development opportunity at the non-member rate. Alternatively, join CAPhO now to register at a lower cost, stay informed, and access additional educational resources to advance your oncology competence.

 

Encourage your colleagues and staff to take advantage of this great learning opportunity and take a moment to print copies of the promotional poster and post them within your pharmacy department or clinic offices. Also, feel free to circulate any email announcements and social media posts to your professional network via email, Facebook, LinkedIn and Twitter. 

 

For more information about #OFD24 and to register visit https://www.capho.org/ofd-2024-0 or contact [email protected].

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article